Objective: This study aims to analyze the causes of postoperative transition from euglycemic diabetic ketoacidosis (EDKA) to diabetic ketoacidosis (DKA), summarize clinical nursing experiences, enhance the recognition and management of such complications, and improve patient prognosis. Methods: A detailed case analysis was conducted on a patient who developed EDKA early after breast cancer surgery, which subsequently transitioned to DKA. A multidisciplinary team (MDT) consultation was employed to formulate a personalized nursing plan. Specific methods included comprehensive clinical data collection, monitoring of blood glucose, urine ketones, and blood ketone levels; implementing dynamic insulin adjustment strategies; providing dietary education and psychological support; and guiding dietary adjustments through nutritional consultations. Results: Through personalized observation, blood glucose management, dietary management, psychological care, and wound care, the patient’s blood and urine ketone levels returned to normal, the flap healed well, and blood glucose was maintained within the normal range. The patient is currently undergoing postoperative adjuvant chemotherapy. Conclusion: For postoperative patients with unexplained nausea, vomiting, and dehydration, regardless of diabetes history, timely testing of blood glucose, blood ketones, blood urea nitrogen, creatinine, electrolytes, and blood gas analysis can facilitate early detection of EDKA. Additionally, personalized management of blood glucose, diet, psychological care, and wound care is crucial for the prevention and treatment of EDKA.
Elzouki, A. and Eledrisi, M. (2020) Management of Diabetic Ketoacidosis in Adults: A Narrative Review. Saudi Journal of Medicine and Medical Sciences, 8, 165-173. https://doi.org/10.4103/sjmms.sjmms_478_19
[3]
Lizzo, J.M., Goyal, A. and Gupta, V. (2024) Adult Diabetic Ketoacidosis. StatPearls.
[4]
Shaka, H., Wani, F., El-Amir, Z., Dahiya, D.S., Singh, J., Edigin, E., et al. (2021) Comparing Patient Characteristics and Outcomes in Type 1 versus Type 2 Diabetes with Diabetic Ketoacidosis: A Review and a Propensity-Matched Nationwide Analysis. Journal of Investigative Medicine, 69, 1196-1200. https://doi.org/10.1136/jim-2021-001901
[5]
Benoit, S.R., Zhang, Y., Geiss, L.S., Gregg, E.W. and Albright, A. (2018) Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality—United States, 2000-2014. MMWR. Morbidity and Mortality Weekly Report, 67, 362-365. https://doi.org/10.15585/mmwr.mm6712a3
[6]
Ibrahim, A., Bayramoglu, B., Hokenek, N.M. and Tekyol, D. (2021) Lactate Clearance during the First 2 Hours after Hospital Admission: A Useful Biomarker for Predicting 30-Day Mortality in Patients with Diabetic Ketoacidosis. International Journal of Clinical Practice, 75, e14204. https://doi.org/10.1111/ijcp.14204
[7]
Long, B., Lentz, S., Koyfman, A. and Gottlieb, M. (2021) Euglycemic Diabetic Ketoacidosis: Etiologies, Evaluation, and Management. The American Journal of Emergency Medicine, 44, 157-160. https://doi.org/10.1016/j.ajem.2021.02.015
[8]
Shi, W.J., Wu, Z.F., Yu, Y.L., et al. (2024) Research Progress in the Etiology of Euglycemic Diabetic Ketoacidosis. Chinese Journal of Diabetes, 32, 317-320.
[9]
Han, L.M., Liu, D., Hu, Q., et al. (2024) Research Progress on Inducement and Pathogenesis of Euglycemic Diabetic Ketoacidosis. Chongqing Medical Journal, 53, 297-301.
[10]
Pandey, D.G. and Sharma, S. (2024) Biochemistry, Anion Gap. StatPearls.
[11]
Kim, J.H., Jang, D., Jo, Y.H., Suh, G.J., Kwon, W.Y., Lee, J.H., et al. (2021) Serum Total Carbon Dioxide as a Prognostic Factor for 28-Day Mortality in Patients with Sepsis. The American Journal of Emergency Medicine, 44, 277-283. https://doi.org/10.1016/j.ajem.2020.04.006
[12]
Slob, E.M.A., Shulman, R. and Singer, M. (2017) Experience Using High-Dose Glucose-Insulin-Potassium (GIK) in Critically Ill Patients. Journal of Critical Care, 41, 72-77. https://doi.org/10.1016/j.jcrc.2017.04.039
[13]
Grant, B. and Chowdhury, T.A. (2022) New Guidance on the Perioperative Management of Diabetes. Clinical Medicine, 22, 41-44. https://doi.org/10.7861/clinmed.2021-0355
[14]
Ghimire, P. and Dhamoon, A.S. (2024) Ketoacidosis. StatPearls.
[15]
Buko, V., Zavodnik, I., Lukivskaya, O., Naruta, E., Palecz, B., Belica-Pacha, S., et al. (2016) Cytoprotection of Pancreatic Β-Cells and Hypoglycemic Effect of 2-Hydroxypropyl-Β-Cyclodextrin: Sertraline Complex in Alloxan-Induced Diabetic Rats. Chemico-Biological Interactions, 244, 105-112. https://doi.org/10.1016/j.cbi.2015.11.014
[16]
Marvanova, M. and Gramith, K. (2018) Role of Antidepressants in the Treatment of Adults with Anorexia Nervosa. Mental Health Clinician, 8, 127-137. https://doi.org/10.9740/mhc.2018.05.127
[17]
Rachdi, C., Damak, R., Fekih Romdhane, F., Ouertani, H. and Cheour, M. (2019) Impact of Sertraline on Weight, Waist Circumference and Glycemic Control: A Prospective Clinical Trial on Depressive Diabetic Type 2 Patients. Primary Care Diabetes, 13, 57-62. https://doi.org/10.1016/j.pcd.2018.09.003
[18]
Liu, Q., Aggarwal, A., Wu, M., Darwish, O.A., Baldino, K., Haug, V., et al. (2022) Impact of Diabetes on Outcomes in Breast Reconstruction: A Systematic Review and Meta-Analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery, 75, 1793-1804. https://doi.org/10.1016/j.bjps.2022.02.053
[19]
Shin, S.H., Koh, Y.G., Lee, W.G., Seok, J. and Park, K.Y. (2022) The Use of Epidermal Growth Factor in Dermatological Practice. International Wound Journal, 20, 2414-2423. https://doi.org/10.1111/iwj.14075
[20]
Zukowski, M.L., Lord, J.L. and Ash, K. (1998) Precautions in Warming Light Therapy as an Adjuvant to Postoperative Flap Care. Burns, 24, 374-377. https://doi.org/10.1016/s0305-4179(98)00029-1
[21]
Simsek, G., Sari, E., Kilic, R. and Bayar Muluk, N. (2016) Topical Application of Arnica and Mucopolysaccharide Polysulfate Attenuates Periorbital Edema and Ecchymosis in Open Rhinoplasty: A Randomized Controlled Clinical Study. Plastic and Reconstructive Surgery, 137, 530e-535e. https://doi.org/10.1097/01.prs.0000479967.94459.1c
